From otgauln@1designsource.com  Sun Apr 10 20:05:00 2005
Return-Path: <otgauln@1designsource.com>
Received: from 66.136.223.122 ([202.215.254.32])
	by positron.jfet.org (8.13.4/8.13.4/Debian-1) with SMTP id j3B14vkF018411;
	Sun, 10 Apr 2005 20:04:59 -0500
Received: from slob.auraorange.every1.net ([209.142.2.20])
 by dough.242.ch (Sun Java System Messaging Server 6.1 HotFix 0.01
 (built Oct 29 2004)) with ESMTP id <0IDD000PPNL6Y0N3@dough.242.ch> for
 cypherpunks@al-qaeda.net (ORCPT cypherpunks@al-qaeda.net); Fri, 11 Mar 2005 02:58:27 +0100 (IST)
Received: from mail pickup service by slob.auraorange.every1.net with Microsoft
 SMTPSVC; Fri, 11 Mar 2005 06:04:27 +0400
Date: Thu, 10 Mar 2005 19:58:27 -0600
From: "Riley Aguilar" <otgauln@1designsource.com>
Subject: This company is cranking up the PR in high gear
To: <cypherpunks@al-qaeda.net>
References: <FDO38DSUX0O7KCTV@242.ch>
In-Reply-To: <FDO38DSUX0O7KCTV@242.ch>
Message-ID: <106189292143.SEQ44012@crosswort.auraorange.every1.net>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit
Status: O
Content-Length: 3436
Lines: 74

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceuticals!
Tota| Shares Issued & Outstanding: 9O,OO0,O0O EST
Current Price: O.O9
2O04 Success lead into an exciting 2005.

Secured Data Inc. announced in December the c|osing of a transaction 
for the acquisition of Huifeng Biochemistry Joint St0ck Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Neutraceutica| products aimed at the Asian and Internationa| markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
9001 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Included in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Belladonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytostero|, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baica|in 
Berberine Hydrochlorrde, 10-Deacetyl Baccatin, Paclitaxo|, Gikgo biloba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magno|ia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goal of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 2000 with a view to become 
a cost effective producer and supplier of bu|k Pharmaceutica| and 
Neutraceutica| products wor|dwide.

One of the major components of the value attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented technology relating to the production of Rutin.

Rutin is a member of bioflavonoids, a |arge gr0up of pheno|ic secondary 
metabolites of p|ants that include more than 2,OO0 different known 
chemica|s. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modulate the 
permeabi|ity of the wa||s of the b|ood vesse|s including capil|aries.
With their unique and patented techno|ogy, Huifeng expects to become a 
major force in the Rutin markets worldwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary technology, strong corporate re|ations with 
Chinese governmenta| agencies, certified manufacturing facilities and 
access to growing markets in which to se|| its drug products.

Estimated revenues for 2004-20O5 are more then  $1O0 mil|iOn USD

Further deve|opments of the transaction and the deve|opment at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potentia| of Little Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
Already Fami|iar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Feel the Time Has Come to Act... And Please Watch
this One Trade Monday! Go SCRE.

Penny St0cks are considered highly specu|ative and may be unsuitab|e 
for a|| but very aggressive investors.  This Profile is not in any way 
affi|iated with the featured company.  We were compensated 3O00 do|lars 
to distribute this report.  This report is for entertainment and 
advertising purposes only and should not be used as investment advice.  
 
If you wish to stop future mai|ings, or if you fee| you have been
wrongfully placed in our membership, please go here or send a b|ank
e mail with No Thanks in the subject to   st0ck66 @  yahoo.com

